MCID: VLV047
MIFTS: 49

Volvulus of Midgut

Categories: Fetal diseases, Gastrointestinal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Volvulus of Midgut

MalaCards integrated aliases for Volvulus of Midgut:

Name: Volvulus of Midgut 56 12
Volvulus 12 29 54 15 32
Intestinal Volvulus 12 43 15 17
Familial Intestinal Malrotation 12 58
Twist of Intestine, Bowel, or Colon 12
Intestinal Malrotation, Familial 56

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant


HPO:

31
volvulus of midgut:
Inheritance autosomal dominant inheritance


Classifications:

Orphanet: 58  
Developmental anomalies during embryogenesis


External Ids:

Disease Ontology 12 DOID:8445
OMIM 56 193250
ICD9CM 34 560.2
MeSH 43 D045822
NCIt 49 C98963
SNOMED-CT 67 9707006
ICD10 32 K56.2
Orphanet 58 ORPHA508410
MedGen 41 C0221210
UMLS 71 C0042961

Summaries for Volvulus of Midgut

Disease Ontology : 12 An intestinal obstruction characterized by abnormal rotation of the intestines.

MalaCards based summary : Volvulus of Midgut, also known as volvulus, is related to filariasis and hernia, hiatus. An important gene associated with Volvulus of Midgut is LAX1 (Lymphocyte Transmembrane Adaptor 1). The drugs Ivermectin and Antiparasitic Agents have been mentioned in the context of this disorder. Affiliated tissues include colon, small intestine and skin, and related phenotypes are depressed nasal bridge and hypertelorism

Wikipedia : 74 A volvulus is when a loop of intestine twists around itself and the mesentery that supports it,... more...

More information from OMIM: 193250

Related Diseases for Volvulus of Midgut

Diseases related to Volvulus of Midgut via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 659)
# Related Disease Score Top Affiliating Genes
1 filariasis 31.2 TLR2 CRP ALB
2 hernia, hiatus 31.0 LAX1 FOXF1 CRP ATP4A ATP12A
3 peptic ulcer disease 30.9 ATP4A ATP12A ALB
4 gastric dilatation 30.9 TNNI3 PLA2G2D CRP ATP4A ATP12A
5 cascade stomach 30.6 ATP4A ATP12A
6 intussusception 30.5 CRP APOLD1 ALB
7 cardiac tamponade 30.3 TNNI3 CRP ALB
8 extrapulmonary tuberculosis 30.3 TLR2 CRP ALB
9 pulmonary tuberculosis 30.3 TLR2 CRP ALB
10 tuberculous peritonitis 30.2 CRP ALB
11 compartment syndrome 30.2 LAX1 GPT CRP ALB
12 abdominal tuberculosis 30.2 GPT CRP ALB
13 cholangitis 30.2 GPT CRP ALB
14 splenic infarction 30.2 GPT CRP ALB
15 aspiration pneumonia 30.2 GPT CRP ATP4A ATP12A ALB
16 dipetalonemiasis 30.2 GPT ALB
17 diaphragmatic hernia, congenital 30.2 FOXF1 ATP4A ATP12A
18 toxic megacolon 30.2 CRP ATP4A ATP12A ALB
19 clostridium difficile colitis 30.1 ATP4A ATP12A ALB
20 cholelithiasis 30.1 GPT CRP ALB
21 obstructive jaundice 30.1 GPT CRP ALB
22 typhoid fever 30.1 GPT CRP ALB
23 deficiency anemia 30.1 CRP ATP4A ATP12A ALB
24 crohn's disease 30.1 TLR2 GCG CRP ALB
25 exanthem 30.1 GPT CRP ATP4A ATP12A ALB
26 pneumonia 30.1 TLR2 GPT CRP ALB
27 ascending cholangitis 30.0 GPT CRP ALB
28 bronchopneumonia 30.0 GPT CRP ALB
29 choledocholithiasis 30.0 GPT CRP ALB
30 active peptic ulcer disease 29.9 CRP ATP4A ATP12A ALB
31 diverticulitis 29.9 CRP ATP4A ATP12A APOLD1 ALB
32 acute cystitis 29.9 TLR2 GPT CRP ALB
33 ileus 29.9 MLN GUCY2C CRP
34 bilirubin metabolic disorder 29.9 GPT CRP ALB
35 emphysematous cholecystitis 29.8 GPT CRP ATP4A ATP12A
36 intestinal perforation 29.8 GPT CRP ATP4A ATP12A ALB
37 hyperuricemia 29.8 GPT CRP ALB
38 esophageal varix 29.8 GPT ATP4A ATP12A ALB
39 pneumatosis cystoides intestinalis 29.8 MLN CRP ATP4A ATP12A
40 duodenal obstruction 29.8 PLA2G2D CRP ATP4A ATP12A ALB
41 hemorrhoid 29.7 CRP ATP4A ATP12A APOLD1 ALB
42 pericardial effusion 29.6 TNNI3 GPT CRP ALB
43 atrial fibrillation 29.6 TNNI3 KCNE1 CRP ALB
44 pulmonary embolism 29.6 TNNI3 CRP ALB
45 peptic esophagitis 29.5 MLN ATP4A ATP12A ALB
46 atrial heart septal defect 29.4 TNNI3 FOXF1 CRP ALB
47 hyperglycemia 29.3 TLR2 PYY GCG ALB
48 gastroesophageal reflux 29.2 PYY MLN GCG ATP4A ATP12A
49 gastroenteritis 29.2 PYY MLN CRP ALB
50 intestinal obstruction 29.2 MLN GUCY2C GPT CRP ATP4A ATP12A

Graphical network of the top 20 diseases related to Volvulus of Midgut:



Diseases related to Volvulus of Midgut

Symptoms & Phenotypes for Volvulus of Midgut

Human phenotypes related to Volvulus of Midgut:

58 31 (show all 13)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 depressed nasal bridge 58 31 hallmark (90%) Very frequent (99-80%) HP:0005280
2 hypertelorism 58 31 hallmark (90%) Very frequent (99-80%) HP:0000316
3 anteverted nares 58 31 hallmark (90%) Very frequent (99-80%) HP:0000463
4 frontal bossing 58 31 hallmark (90%) Very frequent (99-80%) HP:0002007
5 intestinal malrotation 58 31 hallmark (90%) Very frequent (99-80%) HP:0002566
6 high forehead 58 31 hallmark (90%) Very frequent (99-80%) HP:0000348
7 volvulus 58 31 hallmark (90%) Very frequent (99-80%) HP:0002580
8 long palpebral fissure 58 31 hallmark (90%) Very frequent (99-80%) HP:0000637
9 constipation 31 HP:0002019
10 telecanthus 31 HP:0000506
11 abnormality of the genitourinary system 31 HP:0000119
12 abdominal distention 31 HP:0003270
13 neonatal intestinal obstruction 31 HP:0005234

Symptoms via clinical synopsis from OMIM:

56
Head:
frontal bossing
high forehead
boxy head

Eyes:
telecanthus
long palpebral fissures

G I:
constipation
intestinal malrotation
neonatal intestinal obstruction
midgut volvulus
abdominal distention and pain
more
G U:
major obstetrical abnormalities

Clinical features from OMIM:

193250

Drugs & Therapeutics for Volvulus of Midgut

Drugs for Volvulus of Midgut (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 50)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ivermectin Approved, Investigational, Vet_approved Phase 4 70288-86-7 6474909
2 Antiparasitic Agents Phase 4
3 Anti-Infective Agents Phase 4
4 Anticonvulsants Phase 4
5 Vitamins Phase 4
6 Pharmaceutical Solutions Phase 4
7 Fat Emulsions, Intravenous Phase 4
8 Soybean oil, phospholipid emulsion Phase 4
9 Parenteral Nutrition Solutions Phase 4
10 Soy Bean Phase 4
11 Liver Extracts Phase 4
12 Milbemycin Phase 3
13 Anthelmintics Phase 3
14
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
15
Phenytoin Approved, Vet_approved Phase 2 57-41-0 1775
16
Rifampicin Approved Phase 2 13292-46-1 5381226 5458213
17
Azithromycin Approved Phase 2 83905-01-5 447043 55185
18
Furosemide Approved, Vet_approved Phase 2 54-31-9 3440
19
Doxycycline Approved, Investigational, Vet_approved Phase 2 564-25-0 54671203
20
Albendazole Approved, Vet_approved Phase 2 54965-21-8 2082
21
Diethylcarbamazine Approved, Investigational, Vet_approved Phase 2 90-89-1 3052
22
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
23
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 2 65-23-6 1054
24 Kava Approved, Investigational, Nutraceutical Phase 2 9000-38-8
25 Micronutrients Phase 2
26 Trace Elements Phase 2
27 Sodium Channel Blockers Phase 2
28 Vitamin B 6 Phase 2
29 Vitamin B Complex Phase 2
30 Psychotropic Drugs Phase 2
31 Nutrients Phase 2
32 Folate Phase 2
33 Diuretics, Potassium Sparing Phase 2
34 Vitamin B9 Phase 2
35 Neurotransmitter Agents Phase 2
36 Antitubercular Agents Phase 2
37 Antibiotics, Antitubercular Phase 2
38 diuretics Phase 2
39 Anti-Bacterial Agents Phase 2
40 Antiprotozoal Agents Phase 2
41 Antimalarials Phase 2
42
Pyridoxal Experimental, Nutraceutical Phase 2 66-72-8 1050
43
Praziquantel Approved, Investigational, Vet_approved Phase 1 55268-74-1 4891
44
Emodepside Investigational, Vet_approved Phase 1 155030-63-0
45 Toltrazuril Phase 1
46 Anesthetics
47 Cola
48 Omega 3 Fatty Acid
49 Tubulin Modulators
50 Antimitotic Agents

Interventional clinical trials:

(show all 42)
# Name Status NCT ID Phase Drugs
1 Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial Completed NCT03052998 Phase 4 Ivermectin
2 Personalized Versus Standardized Parenteral Nutrition for Preterm Infants With a Birth Weight Greater Than 1250 Grams: a Multicenter Randomized Phase IV Clinical Trial Not yet recruiting NCT03693287 Phase 4 Standardized-parenteral nutrition (S-PN);Personalized-parenteral nutrition (P-PN)
3 Low Dose Parenteral Fat for the Prevention of Parenteral Nutrition Associated Cholestasis in Neonates With Congenital/Acquired Gastrointestinal Disorders Terminated NCT01373918 Phase 4 Intralipid;Intralipid
4 A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus Completed NCT00790998 Phase 3 Moxidectin;Ivermectin
5 Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis Completed NCT03238131 Phase 3 Ivermectin;Albendazole
6 A Randomized, Double Blind, Parallel Trial in the Democratic Republic of Congo (DRC) Comparing the Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Treatment of Onchocerciasis Not yet recruiting NCT03876262 Phase 3 Moxidectin;Ivermectin
7 Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012 Unknown status NCT01730313 Phase 2 Pyridoxine;Sodium Valproate;Phenytoin;Placebo
8 A Randomized, Single-Ascending Dose, Ivermectin-Controlled, Double-Blind, Safety, Tolerability, Pharmacokinetic, and Efficacy Study Of Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection Completed NCT00300768 Phase 2 2 mg moxidectin;ivermectin 150 mcg/kg;4 mg moxidectin;8 mg moxidectin
9 Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala Completed NCT00127504 Phase 2 Rifampin;Azithromycin
10 MANAGEMENT OF THE PATIENT WITH ACUTE ABDOMEN SUBMITTED TO URGENT ABDOMINAL SURGERY: a Pilot Randomized Multicentre Study Completed NCT01911702 Phase 2
11 Doxycycline for the Treatment of Nodding Syndrome: A Phase II, Randomised Placebo Controlled Trial Recruiting NCT02850913 Phase 2 Doxycycline
12 Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis Enrolling by invitation NCT04188301 Phase 2 IVM w/ ALB;Single dose of IDA;Three daily doses of IDA
13 Multicenter, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Ivermectin in Mild Virus-positive Subjects (SARS-CoV)-2 With or Without Symptoms Not yet recruiting NCT04407507 Phase 2 Ivermectin;Placebo
14 A Single-Center, Open-Label, Single-Dose Study To Assess The Pharmacokinetics, Safety, And Tolerability Of Moxidectin In Subjects Aged 4 To 11 Years ( >=12 kg) With Or Without Onchocerca Volvulus Infection Withdrawn NCT01035619 Phase 2 moxidectin
15 A Phase 1, Single-Blind, Randomized, Placebo Controlled, Parallel-Group, Multiple-Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects Completed NCT03383614 Phase 1 LSF emodepside (BAY 44-4400) or matching placebo
16 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers Completed NCT03012828 Phase 1 Moxidectin
17 Phase1,Randomized,Open-Label,Parallel-Group,Relative Bioavailability Study to Investigate PK,Including Food Effect,Safety and Tolerability of Single Doses of New Immediate Release Tablet Formulations of Emodepside (BAY 44-4400),Compared to Oral Solution,in Healthy Male Subjects Completed NCT03383523 Phase 1 Emodepside (BAY 44-4400)
18 Bariatric Embolization Trial for the Obese Nonsurgical Not yet recruiting NCT03601273 Phase 1
19 Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417 Unknown status NCT01880918
20 The Effect of Combined General-epidural vs General Anaesthesia on Postoperative Intestinal Function Recovery and Infection in Neonates and Infants Undergoing Gastrointestinal Surgery: a Prospective, Randomised, Controlled Trial Unknown status NCT03056261
21 Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery Unknown status NCT03266315
22 Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease Approved for marketing NCT03072667 Omegaven
23 Best Management of Sigmoid Volvulus: A Prospective Randomized Trial Completed NCT01682395
24 Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients Completed NCT04360525
25 Prenatal Diagnosis of Antenatal Midgut Volvulus: Specific Ultrasound Features Completed NCT03362450
26 Prenatal Ultrasound Screening of Intestinal Malrotation With a Higher Risk of Volvulus: Value of The Relative Position of The Superior Mesenteric Artery and Vein. Future of the Children With an Antenatal Malrotation Suspicion Completed NCT03356314
27 a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™ Completed NCT01301417
28 Systematic Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus Completed NCT04363125
29 Determination of the Prevalence of LF Infection in Districts Not Included in LF Control Activities and of the Basis for Integrated Implementation of LF - Onchocerciasis Elimination Strategies in Potentially Co-endemic Areas Completed NCT03131401
30 Regional Haemoglobin Oxygen Saturation in the Splanchnic Circulation in Neonates With Gastroschisis; Quantifying and Qualifying the Role for Routine Monitoring Completed NCT03533439
31 Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast Completed NCT02032043 Annual versus Semiannual Albendazole plus Ivermectin MDA
32 Health Related Quality of Life of Patients With Abdominal Wall Defects Completed NCT03960320
33 Role of Omega-3 Fish Oil Fatty Acids on Depression Among HIV-seropositive Pregnant Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial Completed NCT01614249
34 Diagnostic Performance of Antenatal Ultrasound in the Localization of Intestinal Structures Involved in Malrotation With a Higher-risk of Volvulus Recruiting NCT03968107
35 Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District Recruiting NCT03653975
36 Host Response to Infection and Treatment in the Filarial Diseases of Humans Recruiting NCT00001230
37 Safety and Efficacy of Endoscopic Assisted Push Gastrostomy Using Gastropexy Technique Recruiting NCT04096456
38 Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis Active, not recruiting NCT03517462 Ivermectin 3Mg Tab
39 Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia Enrolling by invitation NCT01905436 Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
40 Yield of Colonoscopy in Children With Bleeding Per Rectum Attending Gastrointestinal Endoscopic Unit In Assuit University Children Hospital Not yet recruiting NCT03596320
41 Early Delivery in Fetal Gastroschisis: a Randomized Controlled Trial of Elective Early Delivery Versus Routine Obstetrical Care Terminated NCT01884324
42 Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement Withdrawn NCT02530086

Search NIH Clinical Center for Volvulus of Midgut

Cochrane evidence based reviews: intestinal volvulus

Genetic Tests for Volvulus of Midgut

Genetic tests related to Volvulus of Midgut:

# Genetic test Affiliating Genes
1 Volvulus 29

Anatomical Context for Volvulus of Midgut

MalaCards organs/tissues related to Volvulus of Midgut:

40
Colon, Small Intestine, Skin, Liver, Spleen, Testes, Eye

Publications for Volvulus of Midgut

Articles related to Volvulus of Midgut:

(show top 50) (show all 8330)
# Title Authors PMID Year
1
Familial intestinal malrotation with midgut volvulus and facial anomalies: a disorder involving a gene controlling the normal gut rotation? 61 56
1519649 1992
2
Small bowel volvulus in two siblings. 61 56
3135012 1988
3
Familial midgut anomalies--a spectrum of defects due to the same cause? 56 61
7246615 1981
4
Familial midgut volvulus. 61 56
5051163 1972
5
Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells. 54 61
20199697 2010
6
Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. 61 54
17202370 2007
7
Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. 54 61
17007942 2006
8
Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms. 54 61
16197589 2006
9
Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density. 54 61
11930325 2002
10
Characterization and expression of enzymatically active recombinant filarial prolyl 4-hydroxylase. 54 61
11522351 2001
11
Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. 54 61
11377205 2001
12
Characterization of the heat-shock protein 60 chaperonin from Onchocerca volvulus. 54 61
10779593 2000
13
T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1. 54 61
9767610 1998
14
Identification of an epitope of a recombinant Onchocerca volvulus protein that induces corneal pathology. 54 61
9297706 1997
15
Molecular characterization and expression of Onchocerca volvulus glutathione reductase. 54 61
9271084 1997
16
Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen. 54 61
8699070 1996
17
A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. 61 54
7836063 1994
18
Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis. 54 61
7520419 1994
19
Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus. 54 61
1602002 1992
20
Analysis of aqueous humour in ocular onchocerciasis. 61 54
2036808 1991
21
Humoral autoimmune response against S-antigen and IRBP in ocular onchocerciasis. 54 61
2365568 1990
22
A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule". 61 54
2365822 1990
23
Characteristics of Intestinal Volvulus and Risk of Mortality in Malawi. 61
32100066 2020
24
Authors' Reply: Characteristics of Intestinal Volvulus and Risk of Mortality in Malawi. 61
32333163 2020
25
Letter to the Editor: Characteristics of Intestinal Volvulus and Risk of Mortality in Malawi. 61
32236728 2020
26
Recurrent sigmoid volvulus in a patient with Parkinson's disease. 61
31838591 2020
27
Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo. 61
32498284 2020
28
Ultrasound markers for prediction of complex gastroschisis and adverse outcome: longitudinal prospective nationwide cohort study. 61
31613023 2020
29
Acute intrathoracic gastric volvulus with retrograde gastric intussusception: A case report of a rare surgical emergency with review of the literature. 61
32563826 2020
30
Proteus Syndrome, a rare case with an unusual presentation: Case report. 61
32563816 2020
31
Historical Elimination of Onchocerciasis from Victoria Nile Focus in Central Uganda Verified Using WHO Criteria. 61
32228786 2020
32
Digestive involvement in a patient with Lambert-Eaton syndrome. 61
32496121 2020
33
Prediction pipeline for discovery of regulatory motifs associated with Brugia malayi molting. 61
32574217 2020
34
Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring. 61
32173745 2020
35
Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation. 61
31870209 2020
36
Acid-Base, Electrolyte and Lactate Abnormalities as Well as Gastric Necrosis and Survival in Dogs With Gastric Dilation-Volvulus Syndrome. A Retrospective Study in 75 Dogs. 61
32482282 2020
37
Incarcerated paraesophageal hernia and gastric volvulus: Management options for the acute care surgeon, an Eastern Association for the Surgery of Trauma master class video presentation. 61
32118829 2020
38
Gastric volvulus and giant Bochdalek hernia in an adult patient that were safely repaired by endoscopic reduction and elective laparoscopic surgery. 61
32484304 2020
39
Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection. 61
32540799 2020
40
Correction to: Pneumatosis cystoides intestinalis induced by the alpha-glucosidase inhibitor complicated from sigmoid volvulus in a diabetic patient. 61
32232554 2020
41
Obstruction After Laparoscopic Roux-en-Y Gastric Bypass: Roux Obstruction and Biliopancreatic Gangrene up to Ligament of Treitz. 61
32253611 2020
42
Prenatal diagnosis of midgut volvulus with jejunal atresia by ultrasonography. 61
32452074 2020
43
Midgut volvulus secondary to congenital malrotation in pregnancy. 61
32414778 2020
44
Adult mesentero-axial gastric volvulus: Case report. 61
32441440 2020
45
Ileal-J-Pouch Volvulus After Restorative Proctocolectomy. 61
32378094 2020
46
Colonic volvulus after laparoscopic left colectomy. 61
32389393 2020
47
Target and Whirl Signs: Volvulus of Intussuscepted Colon in an Infant. 61
30710705 2020
48
Integrating Multiple Biomarkers to Increase Sensitivity for the Detection of Onchocerca volvulus Infection. 61
31201416 2020
49
Caecal herniation and volvulus through the foramen of Winslow: a rare presentation. 61
31533193 2020
50
Endoscopic sigmoidopexy with placement of a Chait catheter: a new procedure to prevent recurrent sigmoid volvulus? 61
31810094 2020

Variations for Volvulus of Midgut

Expression for Volvulus of Midgut

Search GEO for disease gene expression data for Volvulus of Midgut.

Pathways for Volvulus of Midgut

GO Terms for Volvulus of Midgut

Biological processes related to Volvulus of Midgut according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium ion export across plasma membrane GO:0036376 9.16 ATP4A ATP12A
2 cellular potassium ion homeostasis GO:0030007 8.96 ATP4A ATP12A
3 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP4A ATP12A

Molecular functions related to Volvulus of Midgut according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 toxic substance binding GO:0015643 9.26 GUCY2C ALB
2 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
3 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
4 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A

Sources for Volvulus of Midgut

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....